The world’s deadliest creature – the mosquito
Herpes zoster virus of shingles
About us We are a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer.
Read morePress releases
- US FDA approves ViiV Healthcare’s Dovato (dolutegravir/lamivudine), the first, once-daily, single-tablet, two-drug regimen for treatment-naïve HIV-1 adults
- ViiV Healthcare announces Juluca (dolutegravir/rilpivirine) maintains HIV viral suppression at 148-weeks
- GSK publishes product sales reporting changes and the impact of IFRS 16 ‘Leases’
Tweets from GSK
-
GSK @GSK
Meet Justin Green, the doctor vital in the discovery of the first treatment for relapsing malaria in 60 years. #WorldMalariaDay #endmalaria
about 14 hours ago -
GSK @GSK
Our chief medical officer for Vaccines, Thomas Breuer, reflects on the WHO-led pilot of our #malariavaccine in Malawi, the science behind it and the importance of long-term, sustainable funding in global health. @WHO #WorldMalariaDay #EndMalaria
about 15 hours ago -
GSK @GSK
After more than a decade of decline, #malaria cases in 2017 were on the rise for a second year in a row in the highest burden countries. Read about how we are fighting malaria. #WorldMalariaDay #EndMalaria
about 18 hours ago
